Antifungal activity of amphotericin B cochleates against Candida albicans infection in a mouse model

Antimicrobial Agents and Chemotherapy

Volumn 44, Issue 6, 2000, Pages 1463-1469

  Zarif, Leila ^a   Graybill, John R ^b   Perlin, David ^c   Najvar, Laura ^b   Bocanegra, Rosie ^b   Mannino, Raphael J ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX;

ANIMAL CELL; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CONTROLLED STUDY; DRUG EFFICACY; HEMOLYSIS; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMPHOTERICIN B; ANIMALS; ANTIBIOTICS, ANTIFUNGAL; CANDIDA ALBICANS; CANDIDIASIS; HUMANS; MICE;

EID: 0034037471     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.44.6.1463-1469.2000     Document Type: Article

References (21)

1. Banerjee, S. N., T. G. Emori, D. H. Culver, R. P. Gaynes, W. R. Jarvis, T. Horan, J. R. Edwards, J. Tolson, T. Henderson, and W. J. Martone. 1991. System T.N.N.I.S. 1980-1989. Secular trends in nosocomial primary blood-stream infections in the United States. Am. J. Med. 91(Suppl. 3B):86S-89S.
2. Bangham, A., and B. A. Pethica. 1959. The adhesiveness of cells and the nature of the chemical groups at their surfaces. Proc. R. Phys. Soc. Edinburg 28:43-52.
3. Bekersky, I., R. M. Fielding, D. Buell, and I. Lawrence. 1999. Lipid-based amphotericin B formulations: from animals to man. PSTT 2:230-236.
4. Bodey, G., B. Bueltmann, W. Duguid, D. Gibbs, H. Hanak, M. Hotchi, G. Mall, P. Martino, F. Meunier, S. Milliken, S. Naoe, M. Okudaira, and D. Seevola. 1992. Fungal infections in cancer patients: an international autopsy survey. Eur. J. Clin. Microbiol. Infect. Dis. 11:99-109.
5. Edwards, J. E., Jr., and S. G. Filler. 1992. Current strategies for treating invasive candidiasis: Emphasis on infections in nonneutropenic patients. Clin. Infect. Dis. 14(Suppl. 1):S106-S113.
6. Engel, R. R., W. Satzger, W. Günther, N. Kathmann, D. Bove, S. Gerke, U. Munch, and H. Hippius. 1992. Double-blind cross-over study of phosphatidylserine vs. placebo in patients with early dementia of the Alzheimer type. Eur. Neuropsychopharmacol. 2:149-155.
7. Gallis, H. A., R. H. Drew, and W. W. Pickard. 1990. Amphotericin B: 30 years of clinical experience. Rev. Infect. Dis. 12:308-329.
8. Holz, R. W. 1979. Mechanism of action of antieukaryotic and antiviral compounds, p. 313-340. In D. Gottlieb and P. D. Shaw (ed.), Antibiotics - 1979. Springer, New York, N.Y.
9. Kucers, A., and N. M. Bennet. 1987. Amphotericin B. p. 1441-1447. In A. Kucers and N. M. Bennett (ed.), The use of antibiotics, 4th ed. J. B. Lippincott, Philadelphia, Pa.
10. Mannino, R. J., and S. Gould-Fogerite. 1997. Antigen cochleate formulations for oral and systemic vaccination, p. 1-9. In M. M. Levine (ed.), New generation vaccines, 2nd ed. Marcel Dekker, New York, N.Y.
11. Meunier, F. 1996. Current clinical issues on mycoses in neutropenic patients. Int. J. Antimicroh. Agents 6:135-140.
12. Pace, S., J. G. Riess, and L. Zarif. 1990. Protective effect, against hemolysis, of perfluoroalkylated chains in surfactants. Artif. Organs 14:201-204.
13. Papahadjopoulos, D., W. J. Vail, K. Jacobson, and G. Poste. 1975. Cochleate lipid cylinders: formation by fusion of unilamellar lipid vesicles. Biochim. Biophys. Acta 394:483-491.
14. Pollard, H. B., A. L. Burns, and E. Rojas. 1988. A molecular basis for synexin-driven, calcium-dependent membrane fusion. J. Exp. Biol. 139:267-286.
15. Sanchez-Migallon, M. P., F. J. Aranda, and J. C. Gomez-Fernandez. 1994. Role of phosphatidylserine and diacylglycerol in the fusion of chromaffin granules with target membranes. Arch. Biochem. Biophys. 314:205-216.
16. Sternberg, S. 1994. The emerging fungal threat. Science 266:1632-1635.
17. Riess, J. G., F. Frezard, J. Greiner, M. P. Krafft, C. Santaella, P. Vierling, and L. Zarif. 1996. Membranes, vesicles and other supramolecular systems made from fluorinated amphiphiles, p. 98-141. In Y. Barenholz and D. Lasic (ed.), Handbook of nonmedical applications of liposomes, vol. III. CRC Press, Boca Raton, Fla.
18. Villardita, C., S. Grioli, G. Salmeri, F. Nicoletti, and G. Pennisi. 1987. Multicenter clinical trial of brain phosphatidylserine in elderly patients with intellectual deterioration Clin. Trials J. 24:84-93.
19. Warnock, D. W. 1991. Amphotericin B: an introduction. J. Antimicrob. Chemother. 28:27-38.
20. Wey, S. B., M. Motomi, and M. A. Pfaller. 1988. Hospital-acquired candidemia. The attributable mortality and excess length of stay. Arch. Intern. Med. 148:2642.
21. Zarif, L., and R. J. Mannino. 2000. Cochleates: lipid-based vehicles for gene delivery - concept, achievements and future development, p. 83-94. In N. Habib (ed.), Cancer gene therapy: past achievements and future challenges - 2000. Plenum Publishing Company, London, England.